Perigon Wealth Management LLC acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 2,053 shares of the semiconductor company’s stock, valued at approximately $916,000.
A number of other large investors have also bought and sold shares of the business. Sankala Group LLC acquired a new position in shares of Synopsys in the fourth quarter valued at approximately $25,000. Elevation Wealth Partners LLC raised its holdings in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 27 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys in the 4th quarter valued at $28,000. IMG Wealth Management Inc. bought a new stake in Synopsys in the 1st quarter valued at $30,000. Finally, Atlas Capital Advisors Inc. acquired a new position in Synopsys in the 4th quarter worth $32,000. 85.47% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research firms recently issued reports on SNPS. Benchmark initiated coverage on Synopsys in a report on Wednesday, July 15th. They set a “buy” rating and a $570.00 price objective for the company. Stifel Nicolaus upped their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Finally, Rosenblatt Securities lifted their price objective on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $565.06.
Insider Transactions at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $404.41 on Wednesday. The business’s 50 day moving average price is $423.21 and its two-hundred day moving average price is $441.54. The company has a market cap of $77.44 billion, a PE ratio of 93.61, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $624.82.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
